[Tech]
Shanghai Stock Exchange
Shanghai
Hangzhou

A-Share's First Humanoid Robot Stock! Unitree Robotics Files for 4.2-Billion-Yuan IPO

March 20, 2026
Share Article:

The Shanghai Stock Exchange has officially accepted the IPO (initial public offering) application from Unitree Robotics for the STAR Market, it said today on its website.

The Chinese startup plans to raise 42.02 billion yuan (US$610 million), marking a historic milestone as it seeks to become the first humanoid robot IPO on the A-share market.

Widely regarded as China's answer to Tesla's Optimus program, the Hangzhou-headquartered Unitree has built a formidable technical moat in both quadruped (robot dog) and humanoid robotics. The company, founded in 2016, gained national fame through multiple high-profile appearances on the Spring Festival Gala, showcasing the agility and coordination of its robotic fleet.

According to the IPO prospectus, Unitree's 2025 revenue is estimated to exceed 1.7 billion yuan, a 335 percent increase year-on-year. From January to September 2025, the company recorded a non-GAAP net profit of 431 million yuan, with expected full-year net profit to hit 600 million yuan.

On the commercialization level, the company achieved a production-to-sales ratio of over 95 percent in the first nine months of 2025, operating at near-full capacity, Unitree said.

This IPO signifies a new era for China's "embodied AI" and humanoid robot sectors, moving from experimental tech to large-scale capital integration.

A-Share's First Humanoid Robot Stock! Unitree Robotics Files for 4.2-Billion-Yuan IPO
Credit: Zhu Shenshen / China Biz Buzz
Caption: Unitree's robot is welcomed by audiences at the Appliance & Electronics World Expo (AWE) 2026 in Shanghai last week.

Editor: Liu Qi

#Shanghai Stock Exchange#Shanghai#Hangzhou
Share Article:

In Case You Missed It...

Shanghai Expects 13 Million Rail Passengers in Spring Travel Surge
FEATURED
[NEWS]
Shanghai Expects 13 Million Rail Passengers in Spring Travel Surge
@ Zhu QingLineMar 20, 2026
[Expats & Ailments] Filipino Blood Cancer Patient Recovers After Receiving CAR-T Cell Therapy in Shanghai
[Expats ailments]
[Expats & Ailments] Filipino Blood Cancer Patient Recovers After Receiving CAR-T Cell Therapy in Shanghai
After two months of comprehensive treatment with cutting-edge CAR-T cell therapy, a 62-year-old terminal-stage patient from the Philippines is cancer-free.
[Expats & Ailments] Filipino Blood Cancer Patient Recovers After Receiving CAR-T Cell Therapy in Shanghai
[Expats & Ailments] Filipino Blood Cancer Patient Recovers After Receiving CAR-T Cell Therapy in Shanghai
[Expats & Ailments] Filipino Blood Cancer Patient Recovers After Receiving CAR-T Cell Therapy in Shanghai
Village Campaign to Boost Urban-Rural Integrated Development
[News]
Village Campaign to Boost Urban-Rural Integrated Development
Shanghai kicks off a high-profile campaign in Mamen Village, Jiading District, to channel much-needed cultural, technological and medical resources to the countryside.